219 related articles for article (PubMed ID: 26868379)
1. A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology.
Hungate EA; Vora SR; Gamazon ER; Moriyama T; Best T; Hulur I; Lee Y; Evans TJ; Ellinghaus E; Stanulla M; Rudant J; Orsi L; Clavel J; Milne E; Scott RJ; Pui CH; Cox NJ; Loh ML; Yang JJ; Skol AD; Onel K
Nat Commun; 2016 Feb; 7():10635. PubMed ID: 26868379
[TBL] [Abstract][Full Text] [Related]
2. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
Xu H; Yang W; Perez-Andreu V; Devidas M; Fan Y; Cheng C; Pei D; Scheet P; Burchard EG; Eng C; Huntsman S; Torgerson DG; Dean M; Winick NJ; Martin PL; Camitta BM; Bowman WP; Willman CL; Carroll WL; Mullighan CG; Bhojwani D; Hunger SP; Pui CH; Evans WE; Relling MV; Loh ML; Yang JJ
J Natl Cancer Inst; 2013 May; 105(10):733-42. PubMed ID: 23512250
[TBL] [Abstract][Full Text] [Related]
3. Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children.
Xu H; Zhang H; Yang W; Yadav R; Morrison AC; Qian M; Devidas M; Liu Y; Perez-Andreu V; Zhao X; Gastier-Foster JM; Lupo PJ; Neale G; Raetz E; Larsen E; Bowman WP; Carroll WL; Winick N; Williams R; Hansen T; Holm JC; Mardis E; Fulton R; Pui CH; Zhang J; Mullighan CG; Evans WE; Hunger SP; Gupta R; Schmiegelow K; Loh ML; Relling MV; Yang JJ
Nat Commun; 2015 Jun; 6():7553. PubMed ID: 26104880
[TBL] [Abstract][Full Text] [Related]
4. A common variant in the CDKN2B gene on chromosome 9p21 protects against coronary artery disease in Americans of African ancestry.
Kral BG; Mathias RA; Suktitipat B; Ruczinski I; Vaidya D; Yanek LR; Quyyumi AA; Patel RS; Zafari AM; Vaccarino V; Hauser ER; Kraus WE; Becker LC; Becker DM
J Hum Genet; 2011 Mar; 56(3):224-9. PubMed ID: 21270820
[TBL] [Abstract][Full Text] [Related]
5. 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response.
Harismendy O; Notani D; Song X; Rahim NG; Tanasa B; Heintzman N; Ren B; Fu XD; Topol EJ; Rosenfeld MG; Frazer KA
Nature; 2011 Feb; 470(7333):264-8. PubMed ID: 21307941
[TBL] [Abstract][Full Text] [Related]
6. Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids.
Duesing K; Fatemifar G; Charpentier G; Marre M; Tichet J; Hercberg S; Balkau B; Froguel P; Gibson F
Diabetologia; 2008 May; 51(5):821-6. PubMed ID: 18368387
[TBL] [Abstract][Full Text] [Related]
7. Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population.
Gutierrez-Camino A; Martin-Guerrero I; Garcia de Andoin N; Sastre A; Carbone Bañeres A; Astigarraga I; Navajas A; Garcia-Orad A
PLoS One; 2017; 12(5):e0177421. PubMed ID: 28481918
[TBL] [Abstract][Full Text] [Related]
8. The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A.
Vijayakrishnan J; Henrion M; Moorman AV; Fiege B; Kumar R; da Silva Filho MI; Holroyd A; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson PD; Hoffmann P; Nöthen MM; Mühleisen TW; Eisele L; Bartram CR; Schrappe M; Greaves M; Hemminki K; Harrison CJ; Stanulla M; Houlston RS
Sci Rep; 2015 Oct; 5():15065. PubMed ID: 26463672
[TBL] [Abstract][Full Text] [Related]
9. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype.
Migliorini G; Fiege B; Hosking FJ; Ma Y; Kumar R; Sherborne AL; da Silva Filho MI; Vijayakrishnan J; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson P; Hoffmann P; Nöthen MM; Mühleisen TW; Eisele L; Zimmermann M; Bartram CR; Schrappe M; Greaves M; Stanulla M; Hemminki K; Houlston RS
Blood; 2013 Nov; 122(19):3298-307. PubMed ID: 23996088
[TBL] [Abstract][Full Text] [Related]
10. Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemia.
Enciso-Mora V; Hosking FJ; Sheridan E; Kinsey SE; Lightfoot T; Roman E; Irving JA; Tomlinson IP; Allan JM; Taylor M; Greaves M; Houlston RS
Leukemia; 2012 Oct; 26(10):2212-5. PubMed ID: 22456626
[TBL] [Abstract][Full Text] [Related]
11. Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol.
Kuchinskaya E; Heyman M; Nordgren A; Söderhäll S; Forestier E; Wehner P; Vettenranta K; Jonsson O; Wesenberg F; Sahlén S; Nordenskjöld M; Blennow E
Br J Haematol; 2011 Mar; 152(5):615-22. PubMed ID: 21241277
[TBL] [Abstract][Full Text] [Related]
12. A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1.
Vijayakrishnan J; Kumar R; Henrion MY; Moorman AV; Rachakonda PS; Hosen I; da Silva Filho MI; Holroyd A; Dobbins SE; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson PD; Hoffmann P; Nöthen MM; Heilmann-Heimbach S; Jöckel KH; Greaves M; Harrison CJ; Bartram CR; Schrappe M; Stanulla M; Hemminki K; Houlston RS
Leukemia; 2017 Mar; 31(3):573-579. PubMed ID: 27694927
[TBL] [Abstract][Full Text] [Related]
13. The Yin and Yang-Like Clinical Implications of the
González-Gil C; Ribera J; Ribera JM; Genescà E
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435487
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951.
Mirebeau D; Acquaviva C; Suciu S; Bertin R; Dastugue N; Robert A; Boutard P; Méchinaud F; Plouvier E; Otten J; Vilmer E; Cavé H;
Haematologica; 2006 Jul; 91(7):881-5. PubMed ID: 16818274
[TBL] [Abstract][Full Text] [Related]
15. Association of CDKN2A/CDKN2B with inflammatory bowel disease in Koreans.
Lee HS; Lee SB; Kim BM; Hong M; Jung S; Hong J; Baek J; Han B; Oh SH; Kim KM; Park SH; Yang SK; Ye BD; Song K
J Gastroenterol Hepatol; 2018 Apr; 33(4):887-893. PubMed ID: 29063720
[TBL] [Abstract][Full Text] [Related]
16. Novel susceptibility variants at the
Qian M; Xu H; Perez-Andreu V; Roberts KG; Zhang H; Yang W; Zhang S; Zhao X; Smith C; Devidas M; Gastier-Foster JM; Raetz E; Larsen E; Burchard EG; Winick N; Bowman WP; Martin PL; Borowitz M; Wood B; Antillon-Klussmann F; Pui CH; Mullighan CG; Evans WE; Hunger SP; Relling MV; Loh ML; Yang JJ
Blood; 2019 Feb; 133(7):724-729. PubMed ID: 30510082
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants at 9p21.3 are associated with risk of esophageal squamous cell carcinoma in a Chinese population.
Lin X; Yan C; Gao Y; Du J; Zhu X; Yu F; Huang T; Dai J; Ma H; Jiang Y; Yin R; Hu Z; Jin G; Xu L; Shen H
Cancer Sci; 2017 Feb; 108(2):250-255. PubMed ID: 27960044
[TBL] [Abstract][Full Text] [Related]
18. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia.
Iacobucci I; Sazzini M; Garagnani P; Ferrari A; Boattini A; Lonetti A; Papayannidis C; Mantovani V; Marasco E; Ottaviani E; Soverini S; Girelli D; Luiselli D; Vignetti M; Baccarani M; Martinelli G
Leuk Res; 2011 Aug; 35(8):1052-9. PubMed ID: 21414664
[TBL] [Abstract][Full Text] [Related]
19. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.
Kim M; Yim SH; Cho NS; Kang SH; Ko DH; Oh B; Kim TY; Min HJ; She CJ; Kang HJ; Shin HY; Ahn HS; Yoon SS; Kim BK; Shin HR; Han KS; Cho HI; Lee DS
Cancer Genet Cytogenet; 2009 Nov; 195(1):59-65. PubMed ID: 19837270
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 9p21 primary open-angle glaucoma susceptibility locus: a review.
Ng SK; Casson RJ; Burdon KP; Craig JE
Clin Exp Ophthalmol; 2014; 42(1):25-32. PubMed ID: 24112133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
